Emerging Therapy

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Dupilumab Lowered IgE Levels in Small Study

Children’s Response to Peanut Patch Therapy Increased Over 60 Months

OIT Drug That Treats 15 Food Allergies Increased Eliciting Threshold but Missed Primary Endpoint

Aquestive’s Sublingual Epinephrine Remains Stable Under High Temperature Test

Vanderbilt Biomedical Research Paves Way for ‘Hypoallergen’ Treatments Against Peanut Allergy

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

Study: Nine Children Suffer Severe Symptoms in OIT Trial

Viaskin Peanut Phase III Trial Falls Short, Still Chance for FDA...

Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy

Eczema Drug Makes Significant Progress as EoE Treatment

DBV Completes Phase III Study of Peanut Patch

Study: Peanut Oral Immunotherapy Combined with Probiotic Achieves Lasting Results

FDA Grants Kaleo Priority Review Status for Auvi-Q Designed for Infants...

New Gene Therapy Could Retrain Immune System to 'Forget' Allergy

New Cancer Treatment May Prove Effective Against Food Allergies

Your School On Our Map

Put Your School on the Map